Siteman Cancer Center opened its first treatment facility in Illinois on Aug. 1. The Swansea, Ill., facility marks Siteman’s sixth location overall.

The treatment center will offer convenient access to nationally recognized cancer care, including clinical trials, for residents of southern and central Illinois and beyond.

Location information

The initial site is at 4000 N. Illinois Lane; however, a new facility is being planned for the Memorial Hospital East campus in nearby Shiloh, Ill., that would open in early 2020. Memorial Hospital East and Washington University Physicians in Illinois Inc. will jointly operate the new Siteman facility.

Click here for a PDF of driving directions and a campus map


Expert physician care at the new satellite will be provided by Washington University Physicians in Illinois Inc. Those physicians are:

  • Radiation oncologist Susan Laduzinsky, MD
  • Radiation oncologist Jason Lee, MD
  • Medical oncologist William J. Popovic, MD
  • Medical oncologist Alfred O. Greco, MD
  • Medical oncologist Guillermo Rodriguez Jr., MD
  • Medical oncologist John L. Visconti, DO

Siteman patients seen in Swansea will have access to the same therapeutic clinical trials offered on Siteman’s main location in the Central West End in St. Louis.

2020 opening at Memorial Hospital East

Siteman At Memorial East Exterior Rendering
Siteman Cancer Center’s newest location, at Memorial Hospital East in Shiloh, Ill., will open in 2020. The facility will replace temporary space at 4000 N. Illinois Lane in Swansea, Ill. (Rendering by: BJC Healthcare)

Preparations are underway to break ground officially on the $38 million, 70,650-square-foot medical office building at Memorial Hospital East, 1404 Cross St. in Shiloh, that will house Siteman’s sixth location overall. The facility will replace temporary space at 4000 N. Illinois Lane in Swansea, where Siteman has been operating.

“We look forward to welcoming patients to this new facility,” said Timothy J. Eberlein, MD, Siteman director and the Spencer T. and Ann W. Olin Distinguished Professor at the School of Medicine. “At Siteman, we’re committed to delivering outstanding cancer care to patients, in a comfortable and convenient setting. We believe strongly in a team approach to cancer care, and our Washington University physicians provide unparalleled expertise and experience in treating all types of cancer, even those that most physicians would consider to be rare.”

The new facility will accommodate multidisciplinary care with radiation oncology and chemotherapy services, and will provide access to therapeutic clinical trials, which are designed to evaluate the effectiveness of innovative cancer therapies. By participating in a clinical trial, patients can gain access to investigational therapies that are not widely available to the public. For the convenience of patients, the new location also will include a diagnostic laboratory and a pharmacy.

“We are very excited to bring Siteman Cancer Center to the Memorial East campus,” said Mark J. Turner, president of Memorial Regional Health Services, which includes Memorial Hospital East and Memorial Hospital Belleville. “This will provide convenient, world-class cancer treatment services to residents throughout the entire region.”

The project now has all necessary approvals from the Illinois Health Facilities & Services Review Board, BJC HealthCare, which owns and operates Memorial Hospital East, and Washington University Physicians In Illinois, Inc. The three-story building also will include clinical space for non-cancer care providers affiliated with Memorial and BJC Medical Group of Illinois.

What is Siteman Cancer Center? What makes it unique?

Siteman Cancer Center is an international leader in cancer treatment, research, prevention, education and community outreach. With the expertise of more than 450 Washington University research scientists and physicians, Siteman treats 50,000 cancer patients each year. So, tumors often considered rare are frequently treated by Washington University physicians at Siteman.

A full range of advanced diagnostic and treatment services are available at Siteman for patients with all types of cancer. Siteman also offers access to support services and educational resources.

Siteman is one of just 49 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers, which puts Siteman in the top 1 percent of U.S. hospitals in terms of cancer research and care. Siteman is the only such cancer center within 200 miles of St. Clair County, and one of just a few cancer centers nationwide to receive the NCI’s highest rating, “Exceptional,” for its research programs.

As an NCI-designated Comprehensive Cancer Center, Siteman:

  • Provides clinical excellence today.
  • Researches tomorrow’s cures.
  • Pushes scientific findings out into the community, making the research relevant to cancer patients in the very near future.

Siteman also is the region’s only member of the National Comprehensive Cancer Network (NCCN), a nonprofit alliance of the nation’s leading cancer centers dedicated to improving the quality, efficiency and effectiveness of cancer care. As an NCCN member, Siteman plays an integral role in developing resources that present valuable information to cancer patients, health-care providers and other groups by creating guidelines for treatment and clinical practice, distributing clinical trial information and planning educational conferences and literature.

As the region’s only NCI-designated Comprehensive Cancer Center and NCCN member, Siteman also is committed to expanding access to cancer prevention and control strategies, clinical studies and genomic and genetic testing throughout the area, efforts aimed at reducing the burden of cancer on our neighbors and communities.

Can patients who were treated at Illinois Oncology Ltd. or The Cancer Treatment Center keep their doctors?

Patients previously treated at Illinois Oncology Ltd. or The Cancer Treatment Center can keep their physicians. They all continue to see patients in the same location, 4000 N. Illinois Lane in Swansea, but do so now as part of Washington University Physicians in Illinois, Inc., a physicians group affiliated with Washington University and dedicated to providing clinical care in Illinois.

The care providers are radiation oncologists Susan Laduzinsky, MD, and Jason Lee, MD; medical oncologists William J. Popovic, MD, Alfred O. Greco, MD, Guillermo Rodriguez Jr., MD, and John L. Visconti, DO; and nurse practitioners Rhonda McCabe, NP, and Alicia Carmack, NP.

What will Siteman’s presence in Illinois look like in the future?

Siteman’s location at 4000 N. Illinois Lane in Swansea opened as a temporary facility on Aug. 1, 2018. Construction of a new replacement facility on the campus of Memorial Hospital East in Shiloh is planned for completion in January 2020.

How does having a Siteman satellite benefit residents of central and southern Illinois?

Having a Siteman Cancer Center satellite in Illinois offers residents more convenient access to specialized care at what is widely recognized as one of the top research-based cancer centers in the nation. Washington University scientists and physicians at Siteman are recipients of $150 million in cancer research grants. The research they conduct, whether in a lab or through clinical trials, can inform the diagnosis and treatment of patients in Illinois, Missouri and beyond. Siteman also conducts more than 400 clinical trials evaluating investigational therapies, including many in collaboration with other leading U.S. cancer centers. Patients at Siteman in Illinois will have access to these trials.

Siteman’s parent institutions, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, also are nationally recognized by U.S. News & World Report, which consistently ranks them, and Siteman, among the best institutions of their kind in the nation.

What are clinical trials? Will Siteman Cancer Center offer them in Illinois?

Siteman Cancer Center offers more than 400 therapeutic clinical trials, which are studies designed to evaluate the effectiveness of innovative cancer therapies. By participating in a clinical trial, patients can gain early access to investigational therapies that are not widely available to the public. Until Siteman’s permanent Illinois location is completed, patients seen in Swansea initially may have to travel to another Siteman facility to access those trials.

What are other benefits of being treated at Siteman Cancer Center?

In addition to having convenient access to highly specialized cancer care, patients in and/or residents of southern and central Illinois benefit from:

  • Streamlined genomic and genetic testing to help identify the cause of a patient’s cancer, and more personalized, targeted treatments based on his or her disease.
  • Continuous improvements to patient care, based on new guidelines for the diagnosis and treatment of cancer, which are updated regularly. Examples include how nurses and radiation therapists are trained to care for oncology patients, and implementing new survivorship and cancer screening recommendations.
  • Implementation of cancer prevention strategies, such as the use of interactive tools, e-books, videos, individual coaching and online cancer risk assessment tools.

Where are all of Siteman’s facilities located?

Siteman’s main location is in St. Louis at Barnes-Jewish Hospital and Washington University School of Medicine. Siteman also has five satellite facilities, in Swansea, Illinois, and at four Missouri locations: Siteman Cancer Center–South County, Christian Hospital in north St. Louis County, Barnes-Jewish West County Hospital in Creve Coeur and Barnes-Jewish St. Peters Hospital in St. Charles County.